Tag: Therapy & Procedures: Misc.
Pharmacomechanical Thrombolysis for Acute DVT Tied to Kidney Injury
Bilateral deep vein thrombosis, single-session treatment, and female sex tied to greater risk
Catheter Ablation Improves A-Fib Outcomes in Racial/Ethnic Minorities
In contrast, much higher event rate seen for racial and ethnic minorities randomly assigned to drug therapy in CABANA trial
Convalescent Plasma May Cut Deaths in Hematologic Cancer and COVID-19
Lower 30-day mortality seen in hospitalized adults, including those admitted to ICU, requiring mechanical ventilation
Convalescent Plasma Use Inversely Linked to COVID-19 Mortality
Reduction in CCP use may have resulted in 29,000 excess deaths in the U.S. from mid-November 2020 to February 2021
ACC: Ultrasound Renal Denervation Cuts BP in Med-Resistant HTN
Reduction in daytime ambulatory systolic blood pressure at two months greater with ultrasound renal denervation versus sham procedure
COVID-19 Antibody Treatments Exceed Expectations in Early Trials
Eli Lilly and Regeneron asking regulators to expand authorization of their drugs based on the new findings
IgG Level in Convalescent Plasma Affects COVID-19 Death Risk
Risk for death reduced with higher versus lower levels of anti-SARS-CoV-2 IgG, but only in patients not receiving mechanical ventilation
Early High-Titer Plasma Reduces Progression of COVID-19
Early administration of high-titer convalescent plasma against SARS-CoV-2 reduces progression in mildly ill older adults
Red Cross Issues Call for More Blood Plasma to Treat COVID-19 Patients
People who have recovered from COVID-19 may have antibodies in their plasma that could boost immunity in current patients
